#Medical science
Opendata.studio
opendata.studio breaks down barriers by providing a user-friendly web platform that empowers researchers and institutions to create, publish, and share […]
NeuMessenger
Every 11 minutes, childhood dementia claims a life. More than 100 rare genetic conditions can lead to this devastating condition, […]
LCAP
By 2026, 90% of global organizations will face IT talent shortages, risking $5.5 trillion in losses. In Australia, 70% of […]
Blitz-OM
Almost every child will have a middle ear infection by age 3 years. For 1 in 4 children infections become […]
MetaMax
Our project integrates the Internet of Bio-Nano Things (IoBNT) with machine learning to enhance digital twinning in biotechnology. Using IoBNT […]
PinPoint Labs
Our indoor positioning technology helps industries that need accurate location data to track inventory, machinery or personnel. Our system complements […]
Hyperdrive Science
Speeding up the journey to health Through improved accuracy of drug candidate selection. The biggest challenge faced by pharmaceutical companies […]
Cytophenix
Cytophenix is revolutionizing the fight against life-threatening infections with their rapid antimicrobial susceptibility tests. Seeking: Long-term partnership and investment
Plasmid Therapy
Plasmid Therapy develops novel, safe, scalable, and affordable solutions to eradicate antimicrobial resistance genes from bacterial populations without disturbing the bacteria themselves or driving resistance adaptations. Seeking: Commercial partners for market expertise
ErythroSight
ErythroSight is developing novel therapeutics to treat retinal diseases using the patient's own red blood cells and has shown strong preclinical results in reducing the severity of currently incurable diseases such as age-related macular degeneration. Seeking: Funding to help drive the next stages of growth